Shanghai Pharmaceuticals Holding Co., Ltd 2607.HK
2607.HK
Shanghai Pharmaceuticals Holding Co., Ltd 1099.HK
Sinopharm Group Co. Ltd. 2196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 1530.HK
3SBio Inc. 3759.HK
Pharmaron Beijing Co., Ltd. 2228.HK
XtalPi Holdings Ltd 2268.HK
WuXi XDC Cayman Inc 0874.HK
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 3320.HK
China Resources Pharmaceutical Group Limited 3347.HK
Hangzhou Tigermed Consulting Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd 1099.HK
Sinopharm Group Co. Ltd. 2196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 1530.HK
3SBio Inc. 3759.HK
Pharmaron Beijing Co., Ltd. 2228.HK
XtalPi Holdings Ltd 2268.HK
WuXi XDC Cayman Inc 0874.HK
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 3320.HK
China Resources Pharmaceutical Group Limited 3347.HK
Hangzhou Tigermed Consulting Co., Ltd.
Performance
| Periode | 2607.HK | 1099.HK | 2196.HK | 1530.HK | 3759.HK | 2228.HK | 2268.HK | 0874.HK | 3320.HK | 3347.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 10.54 % | 3.72 % | 69.96 % | 136.45 % | 88.98 % | 137.79 % | 114.44 % | 7.72 % | -2.67 % | 65.23 % |
| YTD | -4.78 % | -11.65 % | 73.18 % | 373.70 % | 75.34 % | 93.44 % | 125.41 % | 0.34 % | -13.97 % | 40.30 % |
| 1Y | -3.86 % | -8.81 % | 65.69 % | 352.48 % | 59.07 % | 19.40 % | 187.58 % | -6.49 % | -19.25 % | 13.86 % |
| 3Y | 7.94 % | 11.91 % | 22.98 % | 365.90 % | 2.15 % | 93.10 % | 143.93 % | -3.67 % | -18.84 % | -28.61 % |
| 5Y | -1.97 % | 15.85 % | -30.22 % | 259.34 % | -47.22 % | 1 766.67 % | 143.93 % | -11.58 % | 21.23 % | -65.38 % |
| 10Y | -33.92 % | -36.15 % | -6.64 % | 217.75 % | 24.17 % | 891.15 % | 143.93 % | -18.63 % | -47.39 % | -62.67 % |
| From the beginning | 1 028.30 % | -0.54 % | 120.00 % | 202.46 % | 24.17 % | 1 323.73 % | 143.93 % | 2 078.05 % | -47.39 % | -62.67 % |